Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N4NJ
|
|||
| Former ID |
DIB000944
|
|||
| Drug Name |
YKP-1358
|
|||
| Indication | Schizoaffective disorder [ICD-11: 6A21] | Phase 1 | [1] | |
| Schizophrenia [ICD-11: 6A20] | Phase 1 | [1] | ||
| Company |
SK Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The pipeline and future of drug development in schizophrenia. Mol Psychiatry. 2007 Oct;12(10):904-22. | |||
| REF 2 | Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers. Clin Pharmacol Ther. 2007 Feb;81(2):252-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.